Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2010
10/14/2010WO2010078906A3 Hydrazides method for production and use thereof as herbicide and insecticide
10/14/2010WO2010057104A3 Pyridoindole modulators of nmda receptor and acetylcholinesterase
10/14/2010WO2010057088A3 Pyrrolidinyl modulators of nicotinic acetylcholine receptors
10/14/2010WO2010009487A8 Chlorophyll catabolites
10/14/2010US20100263062 Methods for screening and compounds that protect against amyloid diseases
10/14/2010US20100261909 Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
10/14/2010US20100261902 Fluoride-Releasing Compositions
10/14/2010US20100261899 Imidazole compounds
10/14/2010US20100261898 Imidazole compounds
10/14/2010US20100261762 Serotonin and norepinephrine reuptake inhibitor
10/14/2010US20100261761 Novel Sulfonylpyrroles
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261758 Heterocyclic amides for use as pharmaceuticals
10/14/2010US20100261757 Insecticidal (Heteroarylalky)alkane Thio and Oxo Amine Derivatives
10/14/2010US20100261755 Isoxazol-3(2h)-one analogs as therapeutic agents
10/14/2010US20100261743 Novel seh inhibitors and their use
10/14/2010US20100261740 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agent
10/14/2010US20100261728 Trp-m8 receptor ligands and their use in treatments
10/14/2010US20100261724 Heterocycle phenyl amide t-type calcium channel antagonists
10/14/2010US20100261722 Hiv inhibiting 5, 6-substituted pyrimidines
10/14/2010US20100261721 Novel Sulphonylpyrroles
10/14/2010US20100261720 Heterocyclic compound and pharmaceutical composition thereof
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261706 Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof
10/14/2010US20100261703 Salt and crystalline forms thereof of a drug
10/14/2010US20100261701 8-Substituted isoquinoline derivative and the use thereof
10/14/2010US20100261699 N-pyrazole-2-pyridine carboxamide derivative
10/14/2010US20100261698 Organic compounds
10/14/2010US20100261696 Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
10/14/2010US20100261687 Substituted piperidines as ccr3 antagonists
10/14/2010US20100261679 CSF-1R, Inhibitors, Compositions, and Methods of Use
10/14/2010US20100261673 Antibacterial compounds and methods of using same
10/14/2010US20100261665 Kinase inhibitor compounds
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010US20100260711 3-aminosulfonyl substituted indole derivatives and methods of use thereof
10/14/2010CA2758251A1 Serotonin and norepinephrine reuptake inhibitor
10/14/2010CA2758146A1 Organic compounds and their uses
10/14/2010CA2758144A1 Cyclic compound having substituted phenyl group
10/14/2010CA2758071A1 Therapeutic compositions and related methods of use
10/14/2010CA2757654A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010CA2757640A1 Indole derivatives and methods for antiviral treatment
10/14/2010CA2757368A1 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010CA2757138A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010CA2756568A1 Kinase inhibitors and method of treating cancer with same
10/14/2010CA2756250A1 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
10/14/2010CA2756104A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
10/14/2010CA2755669A1 Anthelmintic agents and their use
10/14/2010CA2753151A1 Substituted piperidines as ccr3 antagonists
10/13/2010EP2239260A1 Novel compounds with antibacterial activity
10/13/2010EP2238988A1 Conjugated prodrugs of cc-1065 analogs
10/13/2010EP2238126A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
10/13/2010EP2238125A1 Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors
10/13/2010EP2238110A1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors
10/13/2010EP1994011B1 Sulfonyl benzimidazole derivatives
10/13/2010EP1937667B1 Benzimidazoles useful as inhibitors of protein kinases
10/13/2010EP1833817B1 Synthesis of ccr5 receptor antagonists
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010EP1204642B1 Fungicides
10/13/2010CN1972918B Pyrimidine derivatives
10/13/2010CN101861313A Phenyl amino pyrimidine compounds and uses thereof
10/13/2010CN101861312A 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-HT7 receptor antagonists
10/13/2010CN101861311A 5-pyridinone substituted indazoles
10/13/2010CN101861304A New thrombin function compounds and pharmaceutical compositions based on them
10/13/2010CN101861302A Pyrrolidine aryl-ether as NK3 receptor antagonists
10/13/2010CN101861093A Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides
10/13/2010CN101857588A 4-aromatic aminoquinazoline derivative and purpose thereof
10/13/2010CN101857573A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/13/2010CN101133036B Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
10/13/2010CN101081843B Non-nucleoside reverse transcriptase inhibitors
10/12/2010US7812178 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors
10/12/2010US7812170 Insecticides
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7812164 steroidal alkaloids; for treatment of disorders mediated by hedgehog pathway such as cancer
10/12/2010US7812162 Enantiomers of 2′-fluoralkyl-6-nitroquipazine as serotonin transporter positron emission tomography imaging agents and antidepressant therapeutics
10/12/2010US7812160 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases
10/12/2010US7812159 Processes for preparing aromatic ethers
10/12/2010US7812043 {2-[(1-cyclopropylmethyl-6-fluoro-1H-indole-3-carbonyl)-amino]-thiazol-5-ylsulfanyl}-acetic acid, used for treating non-insulin dependent diabetes, dyslipidemia, hyperlipidemia, hypertension, obesity and as dietetics
10/12/2010US7812041 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812036 Androgens
10/12/2010US7812031 Pyrimidine derivatives as orexin receptor antagonists
10/12/2010US7812026 Imidazole derivatives having a positive allosteric GABAB receptor modulator effect and methods of use
10/12/2010US7812025 neuroprotectants such as 4-biphenyl-3-yl-N-pyridin-3-ylpiperazine-1-carboxamide effective in prevention and treatment of cerebrovascular disorders such as necrosis, hemorrhages, injuries, as antidepressants and/or anxiolytic agents
10/12/2010US7812021 {(3RS,4SR)-3-(3,4-dichloro-phenyl)-4-[(RS)-1-(4-trifluoromethyl-phenoxy)-ethyl]-pyrrolidin-1-yl}-(4-methanesulfonyl-piperazin-1-yl)-methanone, for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder
10/12/2010US7812016 HIV integrase inhibitors such as 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-7[5-(4-fluorobenzyl)-1,3,4-oxadiazol-2-yl]-1,6-naphthyridin-8-ol, useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC
10/12/2010CA2478283C Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
10/12/2010CA2470578C Tetrahydroquinoline analogues as muscarinic agonists
10/12/2010CA2467838C Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/12/2010CA2419552C Substituted pyrazoles
10/12/2010CA2407149C Melanin-concentrating hormone antagonist
10/12/2010CA2339761C Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
10/12/2010CA2223062C 3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
10/07/2010WO2010114957A1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
10/07/2010WO2010114896A1 Substituted indolo-pyridinone compounds
10/07/2010WO2010114179A1 3-[1,4]oxazepane-4-pyrimidone derivatives
10/07/2010WO2010113986A1 Use of pyridazinone compound for control of harmful arthropod pests
10/07/2010WO2010113957A1 Pharmaceutical composition for treating or preventing glaucoma
10/07/2010WO2010113848A1 Isothiourea derivative or isourea derivative having bace1 inhibitory activity
1 ... 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 ... 1080